A randomized controlled trial to confirm the antianginal effect of T89 in patients with stable ischemic heart disease (ORESA): Rationale and design
Confirmative Phaselll Global Clinical Trial of a Botanical Drug in Patients with Chronic Stable Angina (CAESA): New Treatment Options for Myocardial Ischemia Heart Disease
Synergism of Chinese Herbal Medicine: Illustrated by Danshen Compound
T89 Phase II Study & T89 Phase III Study
Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial